1 / 106

Suits and Cases: Potential Pitfalls in the management of Poisoned Patients

Suits and Cases: Potential Pitfalls in the management of Poisoned Patients. John Kashani DO St. Josephs Regional Medical Center New Jersey Poison Center. Case 1.

glain
Download Presentation

Suits and Cases: Potential Pitfalls in the management of Poisoned Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Suits and Cases: Potential Pitfalls in the management of Poisoned Patients John Kashani DO St. Josephs Regional Medical Center New Jersey Poison Center

  2. Case 1 • An 18 year old female, with a past medical history significant for asthma and depression, presents to the ED for shortness of breath • She has a respiratory rate of 34, is diaphoretic, is actively vomiting and appears confused

  3. Case 1 • Her blood pressure is 90/54, Heart rate is 150 and a rectal temperature is 102. farenheit and pulse oximetry is 99% on supplemental oxygen • Her mother states that this is the worst asthma attack she has ever had • She is emergently intubated

  4. Case 1 • Shortly after being intubated she seizes and develops ventricular fibrilation • Despite your best efforts she dies • An autopsy is requested by the family • A post mortem salicylate level was 150mg/dL

  5. Introduction • Salicylates are the most widely used analgesic, anti-pyretic and anti-inflamatory and is the standard for the comparison and evaluation of others • Because salicylates are so widely available the potential for misuse is often underappreciated

  6. Introduction • The physician taking care of the salicylate intoxicated patient must be familiar with the pathophysiology, pharmakokinetics, potential pitfalls, and treatment options

  7. Sources of Salicylates • Found in Willow bark (Salix alba vulgaris) • Available in a multitude of formulas/preparations • Over-the-counter (pepto-bismol) • Topical preparation (wart removal) • Combinations (excedrin, fiorinal, percodan) • Other (oil of wintergreen)

  8. Pharmakokinetics • Peak levels • Regular preparations • Enteric coated • Liquids preparations • Overdose • Distribution • Metabolism • Excretion

  9. Distribution • Volume of distribution (Vd) • Apparent volume the drug is dissolved in • Measured in Liters or Liters/Kg • not a real volume

  10. Salicylates: Toxic Dose • Therapeutic Range: 10–20 mg/kg • Mild Toxicity: 150 mg/kg • Moderate Toxicity: 150-300 mg/kg • Severe Toxicity: > 300 mg/kg

  11. Inflamatory Mediators • Inhibits cyclooxygenase • Decrease in prostaglandins • Increase leukotrienes • Increases microvascular permeability

  12. matrix pyruvate acetyl-CoA CO2 NADH NAD+ citrate oxaloacetate NADH NAD+ malate isocitrate NAD+ CO2 NADH a-ketoglutarate fumarate FADH2 NAD+ CO2 NADH succinyl-CoA succinate FAD

  13. Glucose Glucose 2 ATP Urea Pyruvate Lactate 6 ATP Pyruvate 4 ATP X ALT NH2 Alanine Alanine Liver Muscle

  14. Respiration • Uncouples oxidative phosphorylation • Disrupts hydrogen ion gradient • Unable to generate ATP using electron transport • Increased oxygen consumption, increased heat production, increased metabolic rate, decreased ATP production, increased CO2 production

  15. H+ H+ H+ H+ H+ H+ H+ H+ intermembrane space R-COO- R-COOH R-COO- R-COOH matrix H+ H+ H+

  16. intermembrane space 3H+ H+ 4H+ 4H+ R-0- 2H+ R-0H CytC I III Q R-0H II IV R-0- + H+ 2H+ ADP + Pi + H+ 4H+ 4H+ H+ O2 H2O succinate ATP + H2O heat 3H+ NADH + H+ matrix

  17. Metabolic • Increased lipolysis • Increased production of ketones • Ketonuria present in almost all overdose patients

  18. Ketone bodies Fatty Acids Acetyl CoA

  19. Metabolic • Hyperglycemia in acute setting • Glycogenolysis • May cause glucosuria • Hypoglycemia may subsequently develop

  20. Metabolic • Causes a respiratory alkalosis • Due to respiratory center stimulation • Increase in respiratory rate and depth

  21. Hematologic • Platelet dysfunction • Inhibition of Vitamin K dependent clotting factors • II, VII, IX, X, Protein C, Protein S • Hypoprothrombinemia

  22. Gastrointestinal Effects • Nausea • Vomiting • Gastritis • Pylorospasm

  23. Neurologic • Occurs from metabolic derangements and salicylate CNS levels • Agitation, irritability • Tinnitus • Occurs at levels of 20-45 mg/dL • Lethargy

  24. Laboratories • Salicylate Level • An Level of 100 mg/dL is extremely worrisome (impending doom) • Chronic Levels of > 30 mg/dL are concerning • Difficulty in interpretation due to variable Vd

  25. Laboratories • Levels should be obtained every 1 to 2 hours until downward trend is observed • Do not rely on a single level • Levels < 20mg/dl and a downward trend can be medically cleared

  26. Case 2 • A 35 year old male presents to the emergency department for profound weakness, bradycardia and emesis • An I stat potassium is 8.5mg/dL and an EKG show a sine wave pattern • IV Calcium chloride is administered and he develops ventricular fibrilitation shortly thereafter

  27. Case 2 • Despite your best efforts he dies • The wife said he has no medical problems, but was recently doing a “cleansing diet” that included herbal teas

  28. Introduction • Digitalis and digitalis like cardiac glycosides (DG’s) are found in a variety plants, toads and pharmaceutical agents • Dried powders and extracts have been used for centuries for medicinal agents and as arrow poisons

  29. Pharmacokinetics • Peak serum concentrations occur in minutes with IV dosing and 1-2 hours after an oral dose • The VD is initially small and increases following a two phase compartment model • Higher in infants and neonates and lower in the elderly

  30. Pharmacokinetics • Tissue distribution takes 6-12 hours • Digoxin crosses the placenta with fetal levels approaching that of the mother • Elimination • Hepatic metabolism • Urinary excretion of unchanged drug

  31. Pathophysiology • Cardiac glycosides inhibit the sodium potassium atp-ase • Responsible for pumping two sodium ions out of the cell for every two potassium ions in to the cell

  32. myocardium 3 Na+ Na+ Na+ Na-KATPase Na+ Na+ 2 K+ K+ Na+ Ca++ SR Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ ATPase Ca++ Ca++ -90 mv

  33. myocardium 3 Na+ Na+ Na+ Na-KATPase Na+ Na+ 2 K+ Na+ Na+ Na+ Na+ Na+ K+ Na+ Na+ Na+ Ca++ Na+ SR Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ ATPase Ca++ Ca++ -90 mv

  34. myocardium 3 Na+ Na+ Na+ Na-KATPase Na+ Na+ 2 K+ Na+ Na+ Na+ Na+ K+ Na+ Na+ Na+ Na+ Na+ Ca++ SR Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ ATPase Ca++ Ca++ Ca++ -90 mv

  35. myocardium 3 Na+ Na+ Na+ Na-KATPase Na+ Na+ 2 K+ Na+ Na+ Na+ Na+ Na+ Na+ K+ Na+ Na+ Na+ [Ca++] Ca++ SR Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ ATPase Ca++ Ca++ Ca++ -90 mv

  36. Inhibition of Na-K-ATPase heart [Nai+] [Cai++] contractility

  37. muscle 3 Na+ Na+ Na+ Na-KATPase Na+ [K+] Na+ 2 K+ Na+ Na+ Na+ Na+ Na+ Na+ K+ Na+ Na+ Na+ [Ca++] Ca++ SR Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ ATPase Ca++ Ca++ Ca++ -90 mv

  38. Inhibition of Na-K-ATPase heart skeletal muscle [Nai+] [Ko+] [Cai++] hyperkalemia contractility

  39. myocardium 3 Na+ Na+ Na+ Na-KATPase Na+ Na+ 2 K+ K+ Na+ Ca++ SR Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ ATPase Ca++ Ca++ -90 mv

  40. myocardium 3 Na+ Na+ Na+ Na-KATPase Na+ Na+ 2 K+ Na+ Na+ Na+ Na+ K+ Na+ Na+ Na+ Na+ Na+ Ca++ Ca++ Ca++ Ca++ SR Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ ATPase Ca++ Ca++ Ca++ -90 mv

  41. myocardium 3 Na+ Na+ Na+ Na-KATPase Na+ Na+ 2 K+ Na+ Na+ Na+ Na+ K+ Na+ Na+ Na+ Na+ Na+ Ca++ Ca++ Ca++ Ca++ SR Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ Ca++ ATPase Ca++ Ca++ Ca++ -90 mv

More Related